$2.12 EPS Expected for Chemed Corporation (CHE)

February 13, 2018 - By Adrian Erickson

 $2.12 EPS Expected for Chemed Corporation (CHE)
Investors sentiment decreased to 1.04 in Q3 2017. Its down 0.14, from 1.18 in 2017Q2. It worsened, as 21 investors sold Chemed Corporation shares while 80 reduced holdings. 29 funds opened positions while 76 raised stakes. 15.40 million shares or 0.81% more from 15.27 million shares in 2017Q2 were reported.
1,150 are owned by Tower Rech Cap Limited Liability (Trc). 23 were accumulated by Glenmede Tru Com Na. Iowa Bankshares invested in 0.2% or 2,110 shares. Wells Fargo And Mn reported 0.01% in Chemed Corporation (NYSE:CHE). Stifel owns 0% invested in Chemed Corporation (NYSE:CHE) for 5,481 shares. 10,747 were reported by Nationwide Fund Advisors. Robeco Institutional Asset Bv has invested 0.04% of its portfolio in Chemed Corporation (NYSE:CHE). Gamco Investors Et Al, a New York-based fund reported 527,204 shares. Numeric Invsts Ltd has 49,900 shares. Price T Rowe Inc Md holds 0.01% in Chemed Corporation (NYSE:CHE) or 182,652 shares. Pnc Fincl Svcs holds 0% or 13,301 shares in its portfolio. Ameritas Investment Partners Incorporated has invested 0.01% in Chemed Corporation (NYSE:CHE). Greenleaf Trust holds 0% or 226 shares in its portfolio. Alliancebernstein Ltd Partnership stated it has 49,903 shares or 0.01% of all its holdings. Investec Asset Management Ltd stated it has 323,231 shares.

Since September 1, 2017, it had 0 insider buys, and 5 selling transactions for $2.82 million activity. The insider Dallob Naomi C sold 750 shares worth $166,568. SAUNDERS DONALD E sold $117,485 worth of stock or 450 shares. $197,460 worth of Chemed Corporation (NYSE:CHE) was sold by LEE SPENCER S on Friday, September 1. $2.23M worth of Chemed Corporation (NYSE:CHE) shares were sold by MCNAMARA KEVIN J.

Analysts expect Chemed Corporation (NYSE:CHE) to report $2.12 EPS on February, 21.They anticipate $0.10 EPS change or 4.95 % from last quarter’s $2.02 EPS. CHE’s profit would be $33.85 million giving it 29.40 P/E if the $2.12 EPS is correct. After having $2.13 EPS previously, Chemed Corporation’s analysts see -0.47 % EPS growth. The stock decreased 1.32% or $3.33 during the last trading session, reaching $249.3. About 33,732 shares traded. Chemed Corporation (NYSE:CHE) has risen 54.48% since February 13, 2017 and is uptrending. It has outperformed by 37.78% the S&P500.

Chemed Corporation (NYSE:CHE) Ratings Coverage

Among 3 analysts covering Chemed (NYSE:CHE), 1 have Buy rating, 0 Sell and 2 Hold. Therefore 33% are positive. Chemed had 16 analyst reports since July 27, 2015 according to SRatingsIntel. The rating was maintained by RBC Capital Markets on Monday, July 27 with “Sector Perform”. RBC Capital Markets maintained Chemed Corporation (NYSE:CHE) rating on Sunday, July 30. RBC Capital Markets has “Hold” rating and $20900 target. The rating was maintained by RBC Capital Markets with “Hold” on Monday, October 2. The firm has “Sector Perform” rating by RBC Capital Markets given on Monday, October 26. Oppenheimer maintained it with “Outperform” rating and $225 target in Friday, October 27 report. RBC Capital Markets maintained it with “Sector Perform” rating and $148 target in Tuesday, November 1 report. As per Thursday, October 26, the company rating was maintained by KeyBanc Capital Markets. The firm earned “Hold” rating on Friday, September 1 by RBC Capital Markets. The company was maintained on Monday, May 2 by RBC Capital Markets. Oppenheimer maintained Chemed Corporation (NYSE:CHE) on Tuesday, September 22 with “Outperform” rating.

Chemed Corporation provides hospice and palliative care services in the United States. The company has market cap of $3.98 billion. It operates through two divisions, VITAS and Roto-Rooter. It has a 54.95 P/E ratio. The firm offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers.

More important recent Chemed Corporation (NYSE:CHE) news were published by: Seekingalpha.com which released: “Chemed Corporation (CHE) CEO Kevin McNamara Q3 2017 Results – Earnings Call …” on October 27, 2017, also Bizjournals.com published article titled: “One of Cincinnati’s largest public companies agrees to $75M settlement with feds”, Seekingalpha.com published: “Chemed: Hospice And…Plumbing?” on April 04, 2017. More interesting news about Chemed Corporation (NYSE:CHE) was released by: Businesswire.com and their article: “Chemed Corporation Increases Quarterly Dividend 7.7%” with publication date: August 04, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: